Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.

por Akira Madarame, Masakatsu Fukuzawa, Yoshiya Yamauchi, Shin Kono, Akihiko Sugimoto, Hayato Yamaguchi, Takashi Morise, Yohei Koyama, Kumiko Uchida, Maya Suguro, Taisuke Matsumoto, Kagawa Yasuyuki, Takashi Kawai, Takao Itoi
Publicado 2021